46 matching records for Anti-B Cell.
anti-interleukin-1.alpha. immunoglobulin g rabbit, .alpha.-ketoglutaric acid, .alpha.-lipoic acid, apomorphine, bos taurus joint capsule, sus scrofa joint capsule, ascorbic acid, bos taurus adrenal gland, sus scrofa adrenal gland, brain-derived neurotrophic...
anti-interleukin-1.alpha. immunoglobulin g rabbit, ascorbic acid, metenkefalin, ersofermin, bos taurus cartilage, sus scrofa cartilage, pork collagen, bos taurus red blood cell, sus scrofa red blood cell, interleukin-3, interleukin-3, beef liver, pork liver...
anti-interleukin-1.alpha. immunoglobulin g rabbit, ascorbic acid, metenkefalin, ersofermin, bos taurus cartilage, sus scrofa cartilage, pork collagen, bos taurus red blood cell, sus scrofa red blood cell, interleukin-3, interleukin-3, beef liver, pork liver...
anti-interleukin-1.alpha. immunoglobulin g rabbit, ascorbic acid, metenkefalin, ersofermin, bos taurus cartilage, sus scrofa cartilage, pork collagen, bos taurus red blood cell, sus scrofa red blood cell, interleukin-3, interleukin-3, beef liver, pork liver...
Anti-Interleukin 1, Alpha Ketoglutaric Acid, Alpha Lipoic Acid, Apomorphine, Articulation capsule, Ascorbic acid, Adrenal, BDNF, Beta endorphin, bFGF, Coelliac plexus, Calcitonin, Cartilage, Colchicum automnale, Collagen, Erythrocytes, Interleukin-12, Inter...
AVOBENZONE, OCTISALATE, and OCTOCRYLENE
Dimethicone
Pyrithione Zinc
PYRITHIONE ZINC
PYRITHIONE ZINC
Stem Cell Germinal Fluid
One or multiple immunoglobulins capable of binding to C3b and/or C3d complement components fixed to red blood cells, and intended to be used in immunohaematological testing of a clinical specimen to detect red blood cell sensitization by complement C3b and/...
A collection of immunoglobulins capable of binding to individual classes of human immunoglobulin and/or complement components fixed to red blood cell antigens, and intended to be used together in testing a clinical specimen to detect red blood cell sensitiz...
One or multiple immunoglobulins capable of binding to C3d complement components fixed to red blood cells and intended to be used in immunohaematological testing of a clinical specimen to detect red blood cell sensitisation by complement C3d, using an agglut...
One or multiple immunoglobulins capable of binding to C3 complement components fixed to red blood cells and intended to be used in immunohaematological testing of a clinical specimen to detect red blood cell sensitisation by complement C3, using an agglutin...
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Rh(D) [RH001] red blood cell antigens from the rhesus system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for K [KEL001] red blood cell antigens from the Kell system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for group AB [ABO003] red blood cell antigens, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for C [RH002] red blood cell antigens from the rhesus system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for C [RH004] red blood cell antigens from the rhesus system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for E [RH003] red blood cell antigens from the rhesus system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for E [RH005] red blood cell antigens from the rhesus system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for group A [ABO001] red blood cell antigens, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for group B [ABO002] red blood cell antigens, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for S [MNS004] red blood cell antigens from the MNS system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Fy^a [FY001] red blood cell antigens from the Duffy system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Jk^a [JK001] red blood cell antigens from the Kidd system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Jk^b [JK002] red blood cell antigens from the Kidd system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for S [MNS003] red blood cell antigens from the MNS system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Fy^b [FY002] red blood cell antigens from the Duffy system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for M [MNS001] red blood cell antigens from the MNS system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for k [KEL002] red blood cell antigens from the Kell system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Le^a [LE001] red blood cell antigens from the Lewis system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for N [MNS002] red blood cell antigens from the MNS system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for P1 [P001] red blood cell antigens from the P system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Le^b [LE002] red blood cell antigens from the Lewis system, using an agglutination method.
Lectin molecules extracted from Dolichos biflorus, capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for group A1 [ABO004] red blood cell antigens, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for C^w [RH008] red blood cell antigens from the rhesus system, using an agglutination method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Ku [KEL005] red blood cell antigens from the Kell system, using an agglutination method.
A material containing antibodies to Rh(D) red blood cell antigens [RH001] from the Rhesus system intended to be used in immunohaematological testing of a clinical specimen, to verify the performance of an antibody screening assay that is used for detecting ...
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing a clinical specimen for Kp^a [KEL003] red blood cell antigens from the Kell system, using an agglutination method.